ATXI — Avenue Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $3.66m
- $0.95m
Annual balance sheet for Avenue Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 8.74 | 3.13 | 3.76 | 6.71 | 1.78 |
| Net Total Receivables | — | — | 0.09 | 0 | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8.91 | 3.25 | 3.96 | 6.84 | 1.85 |
| Total Assets | 8.91 | 3.25 | 3.96 | 6.84 | 1.85 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.12 | 0.886 | 0.509 | 3.58 | 1.2 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 2.12 | 0.886 | 0.509 | 2.94 | 0.268 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 6.8 | 2.36 | 3.45 | 3.9 | 1.58 |
| Total Liabilities & Shareholders' Equity | 8.91 | 3.25 | 3.96 | 6.84 | 1.85 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |